.jpeg)
Nasdaq-listed biopharmaceutical company Windtree Therapeutics has announced its intention to acquire up to $700 million worth of BNB, the native cryptocurrency of the BNB Chain. This significant investment follows a recent all-time high for BNB and aligns with a growing trend of publicly traded companies diversifying their treasuries with digital assets.
Windtree Therapeutics' Strategic BNB Acquisition
Windtree Therapeutics, based in Warrington, Pennsylvania, and trading under the ticker WINT on the Nasdaq, revealed its plan to bolster its balance sheet with BNB. The company is raising capital through a combination of an equity line of credit and a stock-purchase agreement to facilitate these purchases. Specifically, they are raising up to $520 million to supplement an initial $200 million commitment, bringing the total potential investment to $700 million.
Key Takeaways
-
Windtree Therapeutics plans to purchase up to $700 million in BNB.
-
The company is raising funds through equity and stock-purchase agreements.
-
Windtree will partner with crypto exchange Kraken for asset custody.
-
This move reflects a broader trend of companies adding crypto to their treasuries.
Partnership with Kraken and Funding Strategy
To manage the digital assets, Windtree Therapeutics has announced a partnership with the cryptocurrency exchange Kraken, which will assist in the custody of the BNB. The funding for this initiative will come from a $500 million equity line of credit provided by an unnamed institutional investor, alongside a $20 million stock-purchase pact with Build and Build Corp. CEO Jed Latkin emphasized the importance of securing these funds for their strategy, pending stockholder approval.
The Growing Trend of Corporate Crypto Treasuries
Windtree Therapeutics joins a growing list of publicly traded companies that are allocating significant portions of their capital to cryptocurrencies. This trend was notably pioneered by MicroStrategy, which has amassed a substantial Bitcoin treasury. Other companies like Semler Scientific and Metaplanet have also made similar investments in various digital assets, including Bitcoin, Ethereum, and XRP. The strategy appears to be aimed at potentially boosting stock prices and offering investors a proxy for digital asset exposure. BNB, the fifth-largest digital coin by market capitalization, was recently trading around $769, having reached an all-time high of $808 earlier in the week.
Sources
-
Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High, Decrypt.
-
News Explorer — This Nasdaq-Listed Drug Company Is Set to Buy $700 Million in BNB, Decrypt.
This article was created with support from AI-driven technology, drawing on multiple reputable sources. The final content has been thoroughly reviewed and edited by BlockzHub's editorial team to ensure accuracy, clarity, and coherence. Original reporting sources are credited whenever appropriate and as required. The opinions expressed in this article do not necessarily represent the official views or positions of BlockzHub. This article is intended for informational purposes only and should not be considered financial or professional advice. Investing involves risk, and you should consult a qualified financial advisor before making any investment decisions.